Cerevel Therapeutics Holdings, Inc.

Ownership Transactions Reported by 24 Insiders

Industry
Pharmaceutical Preparations
Location
222 Jacobs Street, Suite 200, Cambridge, MA

Insiders trading volume in the past year

Cerevel Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abraham Ceesay President $1.23M Feb 6, 2023
Bain Capital Investors Llc Director, 10%+ Owner $0 Aug 1, 2024
Ronald C. Renaud JR President & CEO, Director $0 Aug 1, 2024
Patrick Deval L Director $0 Aug 1, 2024
Paul D. Burgess Chief Business Development and Strategic Operations Officer $0 Aug 1, 2024
Gabrielle Sulzberger Director $0 Aug 1, 2024
Kathleen Tregoning Chief Corporate Affairs Officer $0 Aug 1, 2024
Norbert Riedel Director $0 Aug 1, 2024
Perceptive Advisors Llc Director $0 Feb 20, 2024
Ruth Mckernan Director $0 Aug 1, 2024
N. Anthony Coles Director $0 -$13.6M -100% Aug 1, 2024
Scott Akamine Chief Legal Officer $0 Aug 1, 2024
Adam Koppel Director, 10%+ Owner $0 Aug 1, 2024
Marijn E. Dekkers Director $0 Aug 1, 2024
Pfizer Inc Former 10% Owner $0 Aug 1, 2024
Ramiro Sanchez Chief Medical Officer $0 -$425K -100% Aug 1, 2024
Mark Bodenrader Senior Vice President, Finance and Chief Accounting Officer $0 Aug 1, 2024
Susan ALTSCHULLER Chief Financial Officer $0 Aug 1, 2024
Douglas E. Giordano Director $0 Aug 1, 2024
Christopher R. Gordon Director, 10%+ Owner $0 Aug 1, 2024
John Renger Chief Scientific Officer $0 -$89.8K -100% Aug 1, 2024
Kenneth DiPietro Chief Human Resources Officer $0 Aug 1, 2024
PF Equity Holdings 1 B.V. 10%+ Owner Mar 31, 2022
Suneet Varma Director Jun 14, 2022

Recent Insider Transactions by Companies or Individuals for Cerevel Therapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.